[Inhibition of phenylalanine hydroxylation during treatment of carcinoid syndrome with p-chlorophenylalanine].
D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D002430:Cecal Neoplasms / Q000188:drug therapy; D002854:Chromatography, Paper; D005260:Female; D006579:Heterozygote; D006801:Humans; D007082:Ileum; D007414:Intestinal Neoplasms / Q000188:drug therapy*; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D010649:Phenylalanine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D010661:Phenylketonurias; D014443:Tyrosine / Q000037:antagonists & inhibitors / Q000097:blood
D000814:Aniline Compounds; D014443:Tyrosine; D010649:Phenylalanine; D006899:Mixed Function Oxygenases